Nutra Pharma’s Focus on Financial Sustainability
Posted on Apr 16th, 2009 by David Isserman Just over 2 weeks ago, we posted a press release to our website outlining a new line of cost-effective contract research services offered to startup and small biopharmaceutical companies. While it may be a surprise to many that we are opening our doors to other companies, we believe that by using the tools, labs, and certifications we already have in place, we can provide a much needed service, while at the same time become more financially sustainable. What is financial sustainability? For Nutra Pharma, this means positioning the company in such a way that we will require less, or no, reliance on external sources of capital to cover our ongoing R&D burn rate. For the past several years, Nutra Pharma has been primarily funded by our Chairman and CEO, Rik J. Deitsch. Even though the company is as strong as ever and Mr. Deitsch has committed to continuing to support the company, it would still be in the best interest of our shareholders to move the company towards becoming financially sustainable. Our contract research services provide the first step in that direction. As we continue to gain traction with our new services, we are also planning to introduce an additional business unit focusing on over-the-counter products that has the potential to provide us with immediate revenue. Although we cannot provide details on the scale or scope of this project, we do plan to release additional information over the next several weeks. With all of the discussion surrounding financial sustainability, it is important to emphasize that our goal remains, first and foremost, to continue developing our drug pipeline. We are researching several exciting drug candidates, and as many of you already know, our pipeline contains several potential blockbuster indications, including Multiple Sclerosis (MS). Becoming financially sustainable does not detract from this focus; it simply allows us to be better positioned for long-term success. To ensure that you receive the most recent news, updates, and blog posts from Nutra Pharma, be sure to subscribe to Nutra Pharma E-Alerts. |

















